Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Co expression System. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106047950A details enzymatic reduction for high-purity intermediates. Offers cost reduction and scalable supply chain solutions for global pharmaceutical manufacturing.
Patent CN105543186A enables high-purity chiral alcohol production with reduced costs and enhanced supply chain reliability for global pharmaceutical manufacturers.